Key Details
Symbol (NSE): AUROPHARMA
Corporate Action
Scheme of Amalgamation (Merger)
Nature of Scheme
Amalgamation/Merger of two wholly owned subsidiaries
Entities Involved
Transferor Company: Auroactive Pharma Private Limited (wholly owned subsidiary)
Transferee Company: Apitoria Pharma Private Limited (wholly owned subsidiary)
Financial Details
Auroactive Pharma Turnover (FY2026): INR 701.3 million
Apitoria Pharma Turnover (FY2026): INR 64,430.8 million
Auroactive Pharma Share Capital: INR 247,00,00,000 consisting of 24,70,00,000 equity shares of INR 10 each
Share Entitlement Ratio
97 equity shares of Apitoria Pharma Private Limited (face value INR 10 fully paid up) for every 10,000 equity shares of Auroactive Pharma Private Limited (face value INR 10 each fully paid up)
Capital Structure Impact
Total New Shares to be Issued: 23,95,900 equity shares of INR 10 each of Apitoria Pharma Private Limited
Regulatory and Approval Status
Approval Status: Proposal approved by board of directors of respective companies and Aurobindo Pharma Limited
Filing Authority: Hon'ble NCLT, Hyderabad
Regulatory Exemption: Transaction exempt from provisions of Regulations 23(2), (3) and (4) of SEBI LODR Regulations 2015
Companies Act Exemption: Does not attract requirements of Section 188 of Companies Act, 2013 per MCA Circular No. 30/2014 dated July 17, 2014
Business Rationale
- Consolidate API businesses under a single entity
- Improve operational efficiency
- Optimize capacity utilization of the Auroactive facility
- Simplification of the Group's corporate structure
Transaction Details
Related Party Status: Auroactive Pharma and Apitoria Pharma are wholly owned subsidiaries of the Company and related parties to each other
Valuation: Transaction at arm's length price based on valuation report from an independent registered valuer
Impact on Shareholders
Aurobindo Pharma Shareholding: No change - the Company is not a party to the Scheme of Amalgamation
Subsidiary Level Change: Ownership restructuring between wholly owned subsidiaries only
Timeline
Board Meeting Date: November 4, 2026
Board Meeting Duration: 4:15 p.m to 6:00 p.m